

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 7.45903669 |
| 2 | regulation of cytokine secretion involved in immune response (GO:0002739) | 6.72898227 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.09514238 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.09514238 |
| 5 | ketone body metabolic process (GO:1902224) | 6.07418869 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.89403910 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.89403910 |
| 8 | regulation of protein activation cascade (GO:2000257) | 5.83850982 |
| 9 | opsonization (GO:0008228) | 5.73368363 |
| 10 | regulation of complement activation (GO:0030449) | 5.66161102 |
| 11 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 5.60408870 |
| 12 | negative regulation of lipase activity (GO:0060192) | 5.58882810 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 5.51807457 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.39188451 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.36230785 |
| 16 | complement activation, alternative pathway (GO:0006957) | 5.31101246 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.22562654 |
| 18 | negative regulation of protein activation cascade (GO:2000258) | 5.20899051 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.01549560 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.01250433 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.00093698 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.99463701 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.99463701 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.99463701 |
| 25 | protein carboxylation (GO:0018214) | 4.95192806 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95192806 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.91269237 |
| 28 | negative regulation of complement activation (GO:0045916) | 4.82532462 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.74177986 |
| 30 | urea cycle (GO:0000050) | 4.73456553 |
| 31 | urea metabolic process (GO:0019627) | 4.73456553 |
| 32 | tryptophan metabolic process (GO:0006568) | 4.67145723 |
| 33 | cysteine metabolic process (GO:0006534) | 4.66471919 |
| 34 | positive regulation of respiratory burst (GO:0060267) | 4.65495737 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.63577213 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 4.54480436 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.43761878 |
| 38 | melanin metabolic process (GO:0006582) | 4.40056572 |
| 39 | melanin biosynthetic process (GO:0042438) | 4.37577263 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.35655081 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.33233958 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 4.32792440 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.32239239 |
| 44 | regulation of lipoprotein metabolic process (GO:0050746) | 4.28462670 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.27672636 |
| 46 | fibrinolysis (GO:0042730) | 4.19098304 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.15405991 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.12728775 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08955564 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.08955564 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.08955564 |
| 52 | protein-lipid complex subunit organization (GO:0071825) | 4.07818777 |
| 53 | lysine metabolic process (GO:0006553) | 4.04103552 |
| 54 | lysine catabolic process (GO:0006554) | 4.04103552 |
| 55 | bile acid metabolic process (GO:0008206) | 4.03126989 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.00672598 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.00672598 |
| 58 | phospholipid efflux (GO:0033700) | 4.00163475 |
| 59 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.94818721 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 3.91926420 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.91547129 |
| 62 | tyrosine metabolic process (GO:0006570) | 3.79559397 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.79282572 |
| 64 | bile acid and bile salt transport (GO:0015721) | 3.79224419 |
| 65 | acute-phase response (GO:0006953) | 3.78272952 |
| 66 | positive regulation of steroid metabolic process (GO:0045940) | 3.77354440 |
| 67 | secondary metabolite biosynthetic process (GO:0044550) | 3.75400852 |
| 68 | complement activation (GO:0006956) | 3.74069217 |
| 69 | cholesterol efflux (GO:0033344) | 3.70985531 |
| 70 | complement activation, classical pathway (GO:0006958) | 3.70571294 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.65377849 |
| 72 | negative regulation of sterol transport (GO:0032372) | 3.63744983 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.63744983 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.62984191 |
| 75 | protein activation cascade (GO:0072376) | 3.60805902 |
| 76 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57335000 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 3.57225627 |
| 78 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 3.56904733 |
| 79 | cellular glucuronidation (GO:0052695) | 3.55207658 |
| 80 | cholesterol transport (GO:0030301) | 3.52753302 |
| 81 | sterol transport (GO:0015918) | 3.52753302 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.49761729 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.48310129 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.47909034 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.44875393 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.44359651 |
| 87 | glycine metabolic process (GO:0006544) | 3.44230051 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.44056251 |
| 89 | arginine metabolic process (GO:0006525) | 3.42384876 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 3.39918345 |
| 91 | regulation of plasminogen activation (GO:0010755) | 3.36660490 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.36435436 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35040426 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.33275394 |
| 95 | amine catabolic process (GO:0009310) | 3.33115330 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.33115330 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.32293750 |
| 98 | serine family amino acid metabolic process (GO:0009069) | 3.31212281 |
| 99 | glutamate metabolic process (GO:0006536) | 3.31105649 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.30379843 |
| 101 | protein-lipid complex assembly (GO:0065005) | 3.29939678 |
| 102 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.29541498 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.27744652 |
| 104 | low-density lipoprotein particle remodeling (GO:0034374) | 3.27734046 |
| 105 | epoxygenase P450 pathway (GO:0019373) | 3.27719386 |
| 106 | axon regeneration (GO:0031103) | 3.27299053 |
| 107 | sterol homeostasis (GO:0055092) | 3.26014128 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.25584326 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.25584326 |
| 110 | phenylpropanoid metabolic process (GO:0009698) | 3.23925137 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.23588417 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.23588417 |
| 113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23402233 |
| 114 | ethanol oxidation (GO:0006069) | 3.23112440 |
| 115 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.22495324 |
| 116 | positive regulation of blood coagulation (GO:0030194) | 3.21048394 |
| 117 | positive regulation of hemostasis (GO:1900048) | 3.21048394 |
| 118 | acetyl-CoA metabolic process (GO:0006084) | 3.20686897 |
| 119 | negative regulation of humoral immune response (GO:0002921) | 3.20052432 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.17165128 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 3.14703753 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 3.14558562 |
| 123 | organic acid catabolic process (GO:0016054) | 3.14558562 |
| 124 | COPII vesicle coating (GO:0048208) | 3.12183221 |
| 125 | Golgi transport vesicle coating (GO:0048200) | 3.12124851 |
| 126 | COPI coating of Golgi vesicle (GO:0048205) | 3.12124851 |
| 127 | regulation of cholesterol transport (GO:0032374) | 3.08682045 |
| 128 | regulation of sterol transport (GO:0032371) | 3.08682045 |
| 129 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03975455 |
| 130 | valine metabolic process (GO:0006573) | 2.92869632 |
| 131 | retinal metabolic process (GO:0042574) | 2.91671710 |
| 132 | xenobiotic catabolic process (GO:0042178) | 2.87258250 |
| 133 | regulation of lipoprotein particle clearance (GO:0010984) | 2.83384247 |
| 134 | branched-chain amino acid catabolic process (GO:0009083) | 2.80096296 |
| 135 | drug catabolic process (GO:0042737) | 2.77622681 |
| 136 | omega-hydroxylase P450 pathway (GO:0097267) | 2.76105829 |
| 137 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.75418674 |
| 138 | regulation of digestive system process (GO:0044058) | 2.73373143 |
| 139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71372727 |
| 140 | positive regulation of humoral immune response (GO:0002922) | 2.68180100 |
| 141 | short-chain fatty acid metabolic process (GO:0046459) | 2.68149050 |
| 142 | beta-amyloid metabolic process (GO:0050435) | 2.66963409 |
| 143 | retinol metabolic process (GO:0042572) | 2.66175531 |
| 144 | cholesterol biosynthetic process (GO:0006695) | 2.64746115 |
| 145 | negative regulation of blood coagulation (GO:0030195) | 2.64423927 |
| 146 | negative regulation of hemostasis (GO:1900047) | 2.64423927 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 2.63242388 |
| 148 | exogenous drug catabolic process (GO:0042738) | 2.62045810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.91070591 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.31603475 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.97697851 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.98339244 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.50677059 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.47021154 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.23078365 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.25766534 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.09994682 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.38738798 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99202583 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.53038055 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33902188 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22424368 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14889100 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98353717 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97294727 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.97130048 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94172751 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.93657608 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83056116 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.79227416 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.68241856 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67382426 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64332824 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61329652 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60363399 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58452638 |
| 29 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.55705391 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55090970 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46542156 |
| 32 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44455091 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41836339 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41190490 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40275829 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.40047219 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39445086 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38827837 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36840384 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36329317 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35393315 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23533742 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22828552 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21527870 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21118329 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21088507 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17612130 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16425207 |
| 49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14921379 |
| 50 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09361212 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06980803 |
| 52 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06422105 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05866255 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03890940 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03765872 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02981464 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02326211 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01524362 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00080411 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99070445 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97701645 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97701645 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97141801 |
| 64 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95007587 |
| 65 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.94126918 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94053170 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93676587 |
| 68 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92158865 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91857279 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90709146 |
| 71 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89952589 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89617563 |
| 73 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.88513328 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87990955 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87273057 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87084327 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87001777 |
| 78 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86502391 |
| 79 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83253111 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82718082 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82499643 |
| 82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82499643 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81572494 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79503774 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79341696 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74892643 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74512289 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74274968 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74042728 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73400714 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72567498 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72496737 |
| 93 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72337450 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.71904792 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.71493449 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71446233 |
| 97 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70354100 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.70342574 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69606806 |
| 100 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69474875 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68299168 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.67943321 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66768120 |
| 104 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66338521 |
| 105 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.66141271 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65986134 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64987160 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64949912 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64154593 |
| 110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.63832076 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.63584484 |
| 112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.63549387 |
| 113 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.63439502 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63386375 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63374583 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.63044165 |
| 117 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62901118 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.62826968 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62826332 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62512443 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.62445939 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61836968 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61352476 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61169941 |
| 125 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.60910875 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.60687681 |
| 127 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.60369636 |
| 128 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.60151944 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59647857 |
| 130 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58768843 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58553014 |
| 132 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.58159893 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57891844 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57753211 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57698330 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57314304 |
| 137 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.56884810 |
| 138 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56552239 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56230764 |
| 140 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55262585 |
| 141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55151935 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54898370 |
| 143 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.54852619 |
| 144 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54384707 |
| 145 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.53190172 |
| 146 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.52923102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.25898981 |
| 2 | MP0005360_urolithiasis | 5.97288464 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.03126582 |
| 4 | MP0005365_abnormal_bile_salt | 4.80922725 |
| 5 | MP0000372_irregular_coat_pigmentation | 4.11606864 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.98919730 |
| 7 | MP0005171_absent_coat_pigmentation | 3.75638138 |
| 8 | MP0003252_abnormal_bile_duct | 3.47370561 |
| 9 | MP0002254_reproductive_system_inflammat | 3.32363768 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 3.29435571 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.25833935 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.08876504 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 3.00101536 |
| 14 | MP0009840_abnormal_foam_cell | 2.83699185 |
| 15 | MP0003195_calcinosis | 2.66831453 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.57172949 |
| 17 | MP0005332_abnormal_amino_acid | 2.41214093 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.29465252 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.26557482 |
| 20 | MP0005083_abnormal_biliary_tract | 2.21936421 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.05928243 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.05251758 |
| 23 | MP0004381_abnormal_hair_follicle | 2.03121014 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.99391437 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.97683508 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.96031698 |
| 27 | MP0000609_abnormal_liver_physiology | 1.93189681 |
| 28 | MP0003303_peritoneal_inflammation | 1.87438098 |
| 29 | MP0000371_diluted_coat_color | 1.78692450 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.78077422 |
| 31 | MP0002090_abnormal_vision | 1.75117802 |
| 32 | MP0005257_abnormal_intraocular_pressure | 1.68405609 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.67709170 |
| 34 | MP0005275_abnormal_skin_tensile | 1.64227214 |
| 35 | MP0000604_amyloidosis | 1.56246995 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.53417820 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.52937505 |
| 38 | MP0002822_catalepsy | 1.51657722 |
| 39 | MP0009764_decreased_sensitivity_to | 1.45182685 |
| 40 | MP0001324_abnormal_eye_pigmentation | 1.44483826 |
| 41 | MP0001790_abnormal_immune_system | 1.42790798 |
| 42 | MP0005387_immune_system_phenotype | 1.42790798 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.41941727 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40298245 |
| 45 | MP0005310_abnormal_salivary_gland | 1.36267694 |
| 46 | MP0003186_abnormal_redox_activity | 1.35578509 |
| 47 | MP0003136_yellow_coat_color | 1.35009753 |
| 48 | MP0005671_abnormal_response_to | 1.32285826 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.31808867 |
| 50 | MP0001944_abnormal_pancreas_morphology | 1.29155326 |
| 51 | MP0002006_tumorigenesis | 1.27988731 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.26185592 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.25451950 |
| 54 | MP0003279_aneurysm | 1.19774377 |
| 55 | MP0003879_abnormal_hair_cell | 1.17781098 |
| 56 | MP0005670_abnormal_white_adipose | 1.16973395 |
| 57 | MP0001764_abnormal_homeostasis | 1.14858322 |
| 58 | MP0008469_abnormal_protein_level | 1.11904131 |
| 59 | MP0004883_abnormal_blood_vessel | 1.11766682 |
| 60 | MP0003868_abnormal_feces_composition | 1.11633362 |
| 61 | MP0009763_increased_sensitivity_to | 1.11223742 |
| 62 | MP0000598_abnormal_liver_morphology | 1.09529112 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.08664899 |
| 64 | MP0005164_abnormal_response_to | 1.07739125 |
| 65 | MP0000685_abnormal_immune_system | 1.07681995 |
| 66 | MP0006082_CNS_inflammation | 1.06147993 |
| 67 | MP0000920_abnormal_myelination | 1.04985429 |
| 68 | MP0003045_fibrosis | 1.01789854 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.00873140 |
| 70 | MP0001800_abnormal_humoral_immune | 0.99204672 |
| 71 | MP0003172_abnormal_lysosome_physiology | 0.97803092 |
| 72 | MP0001756_abnormal_urination | 0.97396256 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.97054828 |
| 74 | MP0003011_delayed_dark_adaptation | 0.96826989 |
| 75 | MP0009785_altered_susceptibility_to | 0.96766685 |
| 76 | MP0002095_abnormal_skin_pigmentation | 0.96241284 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.95662003 |
| 78 | MP0003436_decreased_susceptibility_to | 0.95589661 |
| 79 | MP0003283_abnormal_digestive_organ | 0.95075838 |
| 80 | MP0004130_abnormal_muscle_cell | 0.95055764 |
| 81 | MP0005647_abnormal_sex_gland | 0.94901905 |
| 82 | MP0002163_abnormal_gland_morphology | 0.94638636 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.94243906 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.93796939 |
| 85 | MP0005023_abnormal_wound_healing | 0.93713951 |
| 86 | MP0001881_abnormal_mammary_gland | 0.91081840 |
| 87 | MP0002075_abnormal_coat/hair_pigmentati | 0.90069938 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.89855977 |
| 89 | MP0005451_abnormal_body_composition | 0.87539482 |
| 90 | MP0002938_white_spotting | 0.86771619 |
| 91 | MP0003724_increased_susceptibility_to | 0.86160067 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.85715005 |
| 93 | MP0004272_abnormal_basement_membrane | 0.83835494 |
| 94 | MP0001958_emphysema | 0.83522531 |
| 95 | MP0001542_abnormal_bone_strength | 0.83175527 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.82620338 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.82426377 |
| 98 | MP0002060_abnormal_skin_morphology | 0.82332191 |
| 99 | MP0004510_myositis | 0.81324985 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.81244849 |
| 101 | MP0002971_abnormal_brown_adipose | 0.80826728 |
| 102 | MP0003633_abnormal_nervous_system | 0.79969479 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.79421670 |
| 104 | MP0000249_abnormal_blood_vessel | 0.78982495 |
| 105 | MP0001661_extended_life_span | 0.78898357 |
| 106 | MP0005367_renal/urinary_system_phenotyp | 0.78551553 |
| 107 | MP0000516_abnormal_urinary_system | 0.78551553 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.77585107 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.75429995 |
| 110 | MP0005000_abnormal_immune_tolerance | 0.74746508 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.74662680 |
| 112 | MP0002168_other_aberrant_phenotype | 0.74614513 |
| 113 | MP0000343_altered_response_to | 0.73425928 |
| 114 | MP0009697_abnormal_copulation | 0.72035859 |
| 115 | MP0002269_muscular_atrophy | 0.71165679 |
| 116 | MP0005408_hypopigmentation | 0.70892270 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.70482053 |
| 118 | MP0002723_abnormal_immune_serum | 0.70454183 |
| 119 | MP0001835_abnormal_antigen_presentation | 0.70324217 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.68704147 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.68299229 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.68234184 |
| 123 | MP0001186_pigmentation_phenotype | 0.68028034 |
| 124 | MP0009046_muscle_twitch | 0.65962481 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.65844155 |
| 126 | MP0005395_other_phenotype | 0.65458585 |
| 127 | MP0005166_decreased_susceptibility_to | 0.65284093 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.65244593 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.64985355 |
| 130 | MP0006054_spinal_hemorrhage | 0.64743220 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.64225887 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.63696512 |
| 133 | MP0003953_abnormal_hormone_level | 0.63677294 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.62517152 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.62426179 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.62386341 |
| 137 | MP0005334_abnormal_fat_pad | 0.62301879 |
| 138 | MP0005253_abnormal_eye_physiology | 0.62114060 |
| 139 | MP0002078_abnormal_glucose_homeostasis | 0.61057799 |
| 140 | MP0000537_abnormal_urethra_morphology | 0.58890485 |
| 141 | MP0001243_abnormal_dermal_layer | 0.57037944 |
| 142 | MP0000858_altered_metastatic_potential | 0.56572673 |
| 143 | MP0005330_cardiomyopathy | 0.56083413 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.55425744 |
| 145 | MP0002419_abnormal_innate_immunity | 0.54949057 |
| 146 | MP0003075_altered_response_to | 0.54935692 |
| 147 | MP0009115_abnormal_fat_cell | 0.54336825 |
| 148 | MP0005025_abnormal_response_to | 0.54083192 |
| 149 | MP0005084_abnormal_gallbladder_morpholo | 0.53994223 |
| 150 | MP0001915_intracranial_hemorrhage | 0.53918721 |
| 151 | MP0003453_abnormal_keratinocyte_physiol | 0.52486257 |
| 152 | MP0003690_abnormal_glial_cell | 0.52402094 |
| 153 | MP0003329_amyloid_beta_deposits | 0.52156386 |
| 154 | MP0008775_abnormal_heart_ventricle | 0.51400755 |
| 155 | MP0003448_altered_tumor_morphology | 0.50482076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.65077734 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.89955334 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.65154159 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.43297641 |
| 5 | Xanthomatosis (HP:0000991) | 5.29869980 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.15166184 |
| 7 | Complement deficiency (HP:0004431) | 5.13638693 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.77130944 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.76568210 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 4.64723868 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.44795256 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.29884729 |
| 13 | Joint hemorrhage (HP:0005261) | 4.17710994 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11645533 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.99790737 |
| 16 | Hyperammonemia (HP:0001987) | 3.87095352 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.86665175 |
| 18 | Abnormality of complement system (HP:0005339) | 3.86184063 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68896319 |
| 20 | Joint swelling (HP:0001386) | 3.62095230 |
| 21 | Epidermoid cyst (HP:0200040) | 3.59482518 |
| 22 | Spontaneous abortion (HP:0005268) | 3.53588400 |
| 23 | Myocardial infarction (HP:0001658) | 3.48891919 |
| 24 | Ketosis (HP:0001946) | 3.47793276 |
| 25 | Hyperglycinuria (HP:0003108) | 3.44128913 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.41713399 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.34403215 |
| 28 | Blue irides (HP:0000635) | 3.29923751 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.29707803 |
| 30 | Hyperglycinemia (HP:0002154) | 3.28669961 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25744773 |
| 32 | Fat malabsorption (HP:0002630) | 3.25581728 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.23477656 |
| 34 | Retinal atrophy (HP:0001105) | 3.21302222 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18103202 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.18103202 |
| 37 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.06416852 |
| 38 | Hypoplasia of the fovea (HP:0007750) | 3.06416852 |
| 39 | White forelock (HP:0002211) | 3.06150878 |
| 40 | Ocular albinism (HP:0001107) | 3.02438204 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02253281 |
| 42 | Hydroxyprolinuria (HP:0003080) | 3.00461306 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 3.00461306 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.96651677 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.94841561 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88873170 |
| 47 | Patchy hypopigmentation of hair (HP:0011365) | 2.88779264 |
| 48 | Skin nodule (HP:0200036) | 2.88530414 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.86224187 |
| 50 | Glomerulonephritis (HP:0000099) | 2.85182536 |
| 51 | Abnormality of the fovea (HP:0000493) | 2.84120362 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.83741104 |
| 53 | Gingival bleeding (HP:0000225) | 2.83073352 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82872718 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.81135945 |
| 56 | Purpura (HP:0000979) | 2.77127916 |
| 57 | Nuclear cataract (HP:0100018) | 2.75395728 |
| 58 | Iris hypopigmentation (HP:0007730) | 2.69875483 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.67873590 |
| 60 | Malnutrition (HP:0004395) | 2.65480022 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.64240920 |
| 62 | Esophageal varix (HP:0002040) | 2.63829233 |
| 63 | Abnormal cartilage morphology (HP:0002763) | 2.62431610 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.61502657 |
| 65 | Emphysema (HP:0002097) | 2.60383140 |
| 66 | Nephritis (HP:0000123) | 2.57709001 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.56300513 |
| 68 | Mitral stenosis (HP:0001718) | 2.55116838 |
| 69 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.54815144 |
| 70 | Ketoacidosis (HP:0001993) | 2.53248871 |
| 71 | Premature rupture of membranes (HP:0001788) | 2.53248589 |
| 72 | Petechiae (HP:0000967) | 2.49915599 |
| 73 | Amyloidosis (HP:0011034) | 2.46759063 |
| 74 | Spastic diplegia (HP:0001264) | 2.42704481 |
| 75 | IgA deficiency (HP:0002720) | 2.40182227 |
| 76 | Lower limb hyperreflexia (HP:0002395) | 2.37646007 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.37548267 |
| 78 | Gout (HP:0001997) | 2.36399339 |
| 79 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.35087177 |
| 80 | Steatorrhea (HP:0002570) | 2.34657761 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.34638092 |
| 82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.34616512 |
| 83 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.33715020 |
| 84 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.33715020 |
| 85 | Albinism (HP:0001022) | 2.32088110 |
| 86 | Abnormal pupillary function (HP:0007686) | 2.30570683 |
| 87 | Vascular calcification (HP:0004934) | 2.29292642 |
| 88 | Peritonitis (HP:0002586) | 2.27609952 |
| 89 | Increased CSF protein (HP:0002922) | 2.26642306 |
| 90 | Right ventricular cardiomyopathy (HP:0011663) | 2.25293541 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.23925503 |
| 92 | Generalized hypopigmentation (HP:0007513) | 2.18994962 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18373253 |
| 94 | Osteolytic defects of the hand bones (HP:0009699) | 2.18373253 |
| 95 | Menorrhagia (HP:0000132) | 2.17142441 |
| 96 | Cholelithiasis (HP:0001081) | 2.16968558 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15702967 |
| 98 | Aortic dissection (HP:0002647) | 2.14379918 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.14229478 |
| 100 | Pancreatitis (HP:0001733) | 2.14181097 |
| 101 | Hypochromic microcytic anemia (HP:0004840) | 2.13514875 |
| 102 | Peripheral hypomyelination (HP:0007182) | 2.11924911 |
| 103 | Spondylolisthesis (HP:0003302) | 2.11621632 |
| 104 | Abnormal delivery (HP:0001787) | 2.11234056 |
| 105 | Metabolic acidosis (HP:0001942) | 2.09470776 |
| 106 | Delayed CNS myelination (HP:0002188) | 2.09015571 |
| 107 | J-shaped sella turcica (HP:0002680) | 2.05634166 |
| 108 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.05254802 |
| 109 | Vasculitis (HP:0002633) | 2.05240267 |
| 110 | Neonatal onset (HP:0003623) | 2.05042393 |
| 111 | Lymphopenia (HP:0001888) | 2.04856711 |
| 112 | Spastic paraparesis (HP:0002313) | 2.04520467 |
| 113 | Thrombophlebitis (HP:0004418) | 2.04518150 |
| 114 | Late onset (HP:0003584) | 2.02786062 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02019817 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 2.02019817 |
| 117 | Lethargy (HP:0001254) | 1.99577556 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.99275077 |
| 119 | Stroke (HP:0001297) | 1.98812387 |
| 120 | Hypopigmentation of the fundus (HP:0007894) | 1.98612298 |
| 121 | Epistaxis (HP:0000421) | 1.97163980 |
| 122 | Nausea (HP:0002018) | 1.96427695 |
| 123 | Abnormal pancreas size (HP:0012094) | 1.95634680 |
| 124 | Irritability (HP:0000737) | 1.95395320 |
| 125 | Restrictive lung disease (HP:0002091) | 1.94843573 |
| 126 | Alkalosis (HP:0001948) | 1.94292657 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94259486 |
| 128 | Protrusio acetabuli (HP:0003179) | 1.92700843 |
| 129 | Paraparesis (HP:0002385) | 1.91853652 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89334181 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.88917811 |
| 132 | Hypoglycemic seizures (HP:0002173) | 1.88250180 |
| 133 | Vomiting (HP:0002013) | 1.88176105 |
| 134 | Abnormality of vitamin metabolism (HP:0100508) | 1.88113931 |
| 135 | Tongue fasciculations (HP:0001308) | 1.87333816 |
| 136 | Polycythemia (HP:0001901) | 1.85233854 |
| 137 | Increased purine levels (HP:0004368) | 1.84615942 |
| 138 | Hyperuricemia (HP:0002149) | 1.84615942 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.83632949 |
| 140 | Gastrointestinal infarctions (HP:0005244) | 1.82672638 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.81776749 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.81108759 |
| 143 | Tetraparesis (HP:0002273) | 1.80357909 |
| 144 | Sensorimotor neuropathy (HP:0007141) | 1.79438430 |
| 145 | Prolonged neonatal jaundice (HP:0006579) | 1.79240491 |
| 146 | Stridor (HP:0010307) | 1.79071460 |
| 147 | Impaired proprioception (HP:0010831) | 1.78292167 |
| 148 | Postural tremor (HP:0002174) | 1.77307804 |
| 149 | Agammaglobulinemia (HP:0004432) | 1.77152742 |
| 150 | Aortic aneurysm (HP:0004942) | 1.76861080 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.75960436 |
| 152 | Heterochromia iridis (HP:0001100) | 1.75239401 |
| 153 | Polyneuropathy (HP:0001271) | 1.75189015 |
| 154 | Recurrent pneumonia (HP:0006532) | 1.73947923 |
| 155 | Generalized hypopigmentation of hair (HP:0011358) | 1.71255071 |
| 156 | Abnormal tarsal ossification (HP:0008369) | 1.69387146 |
| 157 | Chronic diarrhea (HP:0002028) | 1.67925133 |
| 158 | Symptomatic seizures (HP:0011145) | 1.65386265 |
| 159 | Hyperglycemia (HP:0003074) | 1.65185315 |
| 160 | Progressive sensorineural hearing impairment (HP:0000408) | 1.64982720 |
| 161 | Upper limb muscle weakness (HP:0003484) | 1.64499722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.74294320 |
| 2 | ERN1 | 4.32802555 |
| 3 | FGFR4 | 3.56479226 |
| 4 | TRIB3 | 3.18564005 |
| 5 | TGFBR2 | 2.81891663 |
| 6 | SIK1 | 2.81459677 |
| 7 | TAOK1 | 2.73038331 |
| 8 | RIPK4 | 2.67993570 |
| 9 | MAP4K1 | 2.55286394 |
| 10 | TNK2 | 2.48446852 |
| 11 | ARAF | 2.48071599 |
| 12 | EIF2AK3 | 2.41209101 |
| 13 | MST1R | 2.40389201 |
| 14 | TYK2 | 2.37860386 |
| 15 | EEF2K | 2.35704416 |
| 16 | LMTK2 | 2.30066808 |
| 17 | MAP3K14 | 2.27834215 |
| 18 | TTN | 2.21539703 |
| 19 | MYLK | 2.20672125 |
| 20 | PIK3CG | 2.19394584 |
| 21 | CAMK1G | 2.11900743 |
| 22 | NEK9 | 1.90091276 |
| 23 | TAOK3 | 1.82844651 |
| 24 | PKN2 | 1.74679678 |
| 25 | PDGFRA | 1.72491468 |
| 26 | EPHB1 | 1.63655651 |
| 27 | IRAK4 | 1.61705469 |
| 28 | ERBB4 | 1.60573041 |
| 29 | TBK1 | 1.59927420 |
| 30 | PRKCI | 1.59197624 |
| 31 | FLT3 | 1.47368401 |
| 32 | LATS1 | 1.47080038 |
| 33 | JAK1 | 1.43797189 |
| 34 | ABL2 | 1.42710259 |
| 35 | INSRR | 1.42569754 |
| 36 | NME2 | 1.41459529 |
| 37 | MAPKAPK3 | 1.39767087 |
| 38 | PTK6 | 1.39267385 |
| 39 | MET | 1.34302712 |
| 40 | GRK1 | 1.31767708 |
| 41 | EPHA3 | 1.31121661 |
| 42 | KDR | 1.30286386 |
| 43 | DDR2 | 1.28335035 |
| 44 | IRAK3 | 1.28137852 |
| 45 | PDK1 | 1.26056999 |
| 46 | PRPF4B | 1.23858225 |
| 47 | JAK3 | 1.22845603 |
| 48 | PRKD2 | 1.22556930 |
| 49 | PHKG1 | 1.19094215 |
| 50 | PHKG2 | 1.19094215 |
| 51 | BMX | 1.15482788 |
| 52 | SMG1 | 1.13052144 |
| 53 | MAPK11 | 1.06501083 |
| 54 | TLK1 | 1.05513846 |
| 55 | FGFR3 | 1.02962917 |
| 56 | NLK | 1.00727715 |
| 57 | MAP3K2 | 1.00525742 |
| 58 | MAP3K10 | 1.00330286 |
| 59 | JAK2 | 0.98442769 |
| 60 | TIE1 | 0.97759329 |
| 61 | CSK | 0.97404319 |
| 62 | IKBKE | 0.96759233 |
| 63 | STK38L | 0.95858156 |
| 64 | RIPK1 | 0.93935901 |
| 65 | MAP3K7 | 0.87373335 |
| 66 | TRPM7 | 0.85407779 |
| 67 | PTK2 | 0.84334205 |
| 68 | MAP3K13 | 0.84152530 |
| 69 | MAP2K6 | 0.82801604 |
| 70 | SYK | 0.81073930 |
| 71 | PIM2 | 0.80729180 |
| 72 | DYRK1B | 0.80689195 |
| 73 | BLK | 0.79732530 |
| 74 | PRKAA2 | 0.79331542 |
| 75 | MAPK12 | 0.79233667 |
| 76 | BRAF | 0.79096911 |
| 77 | IKBKB | 0.78827891 |
| 78 | PDK2 | 0.78249511 |
| 79 | CSF1R | 0.76960248 |
| 80 | MAP3K3 | 0.74093850 |
| 81 | PASK | 0.73651842 |
| 82 | CHUK | 0.73317818 |
| 83 | LRRK2 | 0.71436849 |
| 84 | GSK3A | 0.70429869 |
| 85 | STK3 | 0.69739286 |
| 86 | CDK6 | 0.69077100 |
| 87 | KIT | 0.68791928 |
| 88 | RPS6KA5 | 0.68692655 |
| 89 | RAF1 | 0.67565564 |
| 90 | NTRK3 | 0.66303654 |
| 91 | MAP2K3 | 0.66099739 |
| 92 | VRK1 | 0.62476117 |
| 93 | FER | 0.61174986 |
| 94 | ACVR1B | 0.60593513 |
| 95 | PBK | 0.60073628 |
| 96 | FRK | 0.59013722 |
| 97 | EPHA2 | 0.58992744 |
| 98 | CDC42BPA | 0.57229039 |
| 99 | PRKCQ | 0.53789817 |
| 100 | MARK3 | 0.53360898 |
| 101 | LYN | 0.51930594 |
| 102 | PRKCH | 0.51698103 |
| 103 | PAK2 | 0.51499337 |
| 104 | PDPK1 | 0.50615895 |
| 105 | DAPK3 | 0.50562633 |
| 106 | FGFR2 | 0.49870499 |
| 107 | PRKACG | 0.49866121 |
| 108 | MAP3K11 | 0.49822999 |
| 109 | MAPK4 | 0.49679029 |
| 110 | AKT2 | 0.49264529 |
| 111 | EPHB2 | 0.48462424 |
| 112 | PAK4 | 0.47978703 |
| 113 | IRAK1 | 0.46966121 |
| 114 | WNK3 | 0.44908787 |
| 115 | MAP2K1 | 0.44896686 |
| 116 | PINK1 | 0.44504165 |
| 117 | PRKAA1 | 0.44272900 |
| 118 | MTOR | 0.43790764 |
| 119 | IRAK2 | 0.42509989 |
| 120 | DAPK1 | 0.42281542 |
| 121 | MAPK7 | 0.41851084 |
| 122 | TESK2 | 0.41748454 |
| 123 | MAP2K4 | 0.40888533 |
| 124 | PDK4 | 0.40877596 |
| 125 | PDK3 | 0.40877596 |
| 126 | PRKCG | 0.40567472 |
| 127 | CDK3 | 0.40415507 |
| 128 | LATS2 | 0.40222905 |
| 129 | PAK3 | 0.40182733 |
| 130 | CAMK2G | 0.39007668 |
| 131 | HIPK2 | 0.38453658 |
| 132 | ABL1 | 0.37197512 |
| 133 | EGFR | 0.37012964 |
| 134 | DAPK2 | 0.36987939 |
| 135 | MAP2K2 | 0.36436472 |
| 136 | FGR | 0.35979306 |
| 137 | PRKCZ | 0.35862978 |
| 138 | IGF1R | 0.35335625 |
| 139 | PRKCE | 0.35011117 |
| 140 | PTK2B | 0.34594778 |
| 141 | ZAP70 | 0.33514616 |
| 142 | PIM1 | 0.33329791 |
| 143 | ZAK | 0.32378225 |
| 144 | CAMK1D | 0.32105811 |
| 145 | MAPKAPK5 | 0.31827245 |
| 146 | PKN1 | 0.30948122 |
| 147 | SGK223 | 0.30902915 |
| 148 | SGK494 | 0.30902915 |
| 149 | CSNK1A1 | 0.30504582 |
| 150 | MST4 | 0.30164818 |
| 151 | PRKD1 | 0.29101962 |
| 152 | EIF2AK1 | 0.28724322 |
| 153 | PRKCB | 0.28363210 |
| 154 | ROCK1 | 0.27272987 |
| 155 | AKT3 | 0.26558115 |
| 156 | RET | 0.26163283 |
| 157 | MAP3K5 | 0.26157276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99652960 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.73735380 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69033282 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.16445825 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06051973 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03340871 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62059496 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43786077 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43092838 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34682126 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34016875 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30725197 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27072982 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24010093 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07596077 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05289197 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03792091 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90154463 |
| 19 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.89197867 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.88675313 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79068547 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78458642 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77950289 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.76462394 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74481592 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74416970 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72867133 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71539328 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68899594 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59424543 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58347423 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57006885 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42439462 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41999319 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40288304 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33784798 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.33459852 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28555175 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27430836 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22507998 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21856787 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20098946 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16789417 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16208463 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13651198 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12483856 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12108953 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.09278466 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09202361 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07168064 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.04889369 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02355601 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01021285 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00424575 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90578629 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87237618 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87192709 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81933107 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76787362 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76061770 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74635347 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70657351 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.69348214 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68284842 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66525377 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64612807 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64334338 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64047165 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63884394 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62220007 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61926872 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61425398 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55067454 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53834386 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53606790 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.53381995 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52773214 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51356275 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48891858 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46802654 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.43793410 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41297715 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40536306 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37750142 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.37138417 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.36618134 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.36057678 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34879553 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34776006 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34558941 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34276611 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.32455399 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30662087 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.30402976 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29092894 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.28579911 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27296703 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.26459870 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24468800 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24202488 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.21396232 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21100442 |
| 103 | Insulin secretion_Homo sapiens_hsa04911 | 0.20656349 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.19937121 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19705363 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.18656325 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16475244 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15571680 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14547156 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.13039396 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.10992971 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.09307818 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.08514402 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07657491 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.06450030 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.06212200 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.04656946 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02677064 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.02316480 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02066185 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.00085290 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0148210 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0034065 |

